Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Agranulocytosis D000380 7 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Anaphylaxis D000707 35 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypoxia D000860 23 associated lipids
Anthrax D000881 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthus Reaction D001183 8 associated lipids
Ascites D001201 25 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Michelotto PV et al. Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training. 2011 Vet. J. pmid:22108190
Nasopoulou C et al. Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism. 2011 Lipids Health Dis pmid:22087726
Sánchez FA et al. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. 2011 J. Biol. Chem. pmid:21757745
Dombrowsky H et al. Ingestion of (n-3) fatty acids augments basal and platelet activating factor-induced permeability to dextran in the rat mesenteric vascular bed. 2011 J. Nutr. pmid:21775525
Tsuda M et al. Platelet-activating factor and pain. 2011 Biol. Pharm. Bull. pmid:21804199
Chan MV et al. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. 2011 Platelets pmid:21806492
Zhou X and He P Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca²⁺]i, nitric oxide, and gap formation in intact venules. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21873500
Alarcón P et al. D-lactic acid interferes with the effects of platelet activating factor on bovine neutrophils. 2011 Vet. Immunol. Immunopathol. pmid:21816488
Machado GB et al. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. 2011 Respir. Res. pmid:21819560
Tsantila N et al. In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. 2011 Angiology pmid:20805097
Zong RK and Liu J [Effects of Chinese herbal medicine Xinfeng Capsule on expressions of platelet-activating factor and interleukins 6 and 17 in peripheral blood of rats with adjuvant arthritis]. 2011 Zhong Xi Yi Jie He Xue Bao pmid:22152774
Smit JJ et al. Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. 2011 PLoS ONE pmid:22194949
Parrill AL et al. Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. 2011 BMC Biochem. pmid:22177013
Tang WZ et al. Dimeric prenylated C6-C3 compounds from the stem bark of Illicium oligandrum. 2011 J. Nat. Prod. pmid:21524101
Ma SG et al. Four new phenolic diglycosides from the roots of Illicium oligandrum. 2011 Carbohydr. Res. pmid:21524732
Yang AP and Chen Q [Correlation between blood-stasis tongue figure and platelet activating factor (PAF) and acetyl hydrolase of PAF (PAF-AH) in patients with primary dysmenorrhea]. 2011 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:21485072
McHowat J et al. Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung. 2011 Am. J. Physiol., Cell Physiol. pmid:21228317
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Fang W et al. Platelet activating factor induces blood brain barrier permeability alteration in vitro. 2011 J. Neuroimmunol. pmid:20870297
Brooks AC et al. CXCL8 attenuates chemoattractant-induced equine neutrophil migration. 2011 Vet. Immunol. Immunopathol. pmid:21040981
Greiner C et al. 2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo. 2011 Br. J. Pharmacol. pmid:21506958
Saihkay HN et al. Validating 123I-metaiodobenzylguanidine as a platelet marker for non-invasive imaging in rabbits. 2011 Jan-Feb J Pharmacol Toxicol Methods pmid:20646985
Cingi C et al. The histopathological effect of thymoquinone on experimentally induced rhinosinusitis in rats. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185737
Neerhof MG et al. The significance of endothelin in platelet-activating factor-induced fetal growth restriction. 2012 Reprod Sci pmid:22534337
Muehlmann LA et al. PAF increases phagocytic capacity and superoxide anion production in equine alveolar macrophages and blood neutrophils. 2012 Res. Vet. Sci. pmid:21820686
Kim HA et al. Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis. 2012 Eur. J. Cancer pmid:21889331
Werner J et al. Multidrug strategies are effective in the treatment of severe experimental pancreatitis. 2012 Surgery pmid:21982067
Xiong J et al. New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation. 2012 Eur J Pharm Sci pmid:22285483
Flaherty MM et al. Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice. 2012 Toxicol. Sci. pmid:22025730
Sharma J et al. Lung endothelial cell platelet-activating factor production and inflammatory cell adherence are increased in response to cigarette smoke component exposure. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:21984569
Samapati R et al. Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. 2012 Am. J. Respir. Crit. Care Med. pmid:22246702
Yao Y et al. Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity. 2012 J. Biol. Chem. pmid:22303003
Du Y et al. Macrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates. 2012 Nat Commun pmid:22910354
Jalil J et al. Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King. 2012 Molecules pmid:22964504
Conejeros I et al. 2-Aminoethoxydiphenyl borate (2-APB) reduces respiratory burst, MMP-9 release and CD11b expression, and increases l-selectin shedding in bovine neutrophils. 2012 Res. Vet. Sci. pmid:21071047
Akbarshahi H et al. Acute lung injury in acute pancreatitis--awaiting the big leap. 2012 Respir Med pmid:22749752
Kolovou V et al. Platelet activating factor levels and metabolism in Tangier disease: a case study. 2012 Lipids Health Dis pmid:22769014
Jia XQ et al. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention]. 2012 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:22464576
Liu M et al. Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion. 2012 PLoS Pathog. pmid:22496650
Vadas P and Perelman B Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cells. 2012 J. Allergy Clin. Immunol. pmid:22460068
Zheng GH et al. Elevated plasma platelet activating factor, platelet activating factor acetylhydrolase levels and risk of coronary heart disease or blood stasis syndrome of coronary heart disease in Chinese: a case control study: a case-control study. 2012 Inflammation pmid:22430230
Bai J et al. Sesquiterpenes from the roots of Illicium dunnianum. 2012 Phytochemistry pmid:22695122
Carosati E et al. 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets. 2012 Curr. Med. Chem. pmid:22709009
Harpavat S et al. Novel treatments for NEC: keeping IBD in mind. 2012 Curr Gastroenterol Rep pmid:22623180
Flasiński M et al. Behavior of platelet activating factor in membrane-mimicking environment. Langmuir monolayer study complemented with grazing incidence X-ray diffraction and Brewster angle microscopy. 2012 J Phys Chem B pmid:22834697
Yuan D and He P Vascular remodeling alters adhesion protein and cytoskeleton reactions to inflammatory stimuli resulting in enhanced permeability increases in rat venules. 2012 J. Appl. Physiol. pmid:22837164
Masliakov VV et al. [Microcirculation in the injured spleen by different operations in children]. 2012 Khirurgiia (Mosk) pmid:23257700
Liu C et al. Clinical significance and expression of PAF and TNF-alpha in seminal plasma of leukocytospermic patients. 2012 Mediators Inflamm. pmid:23209346
Zhang XT et al. [Study on pharmacokinetics of ginkgolide B injection in Beagle dogs]. 2012 Zhong Yao Cai pmid:23213741
Mirpuri J et al. Lactobacillus rhamnosus (LGG) regulates IL-10 signaling in the developing murine colon through upregulation of the IL-10R2 receptor subunit. 2012 PLoS ONE pmid:23272193